| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7093572d35e216f0747e7fcfeb67c4b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_140061dae4376c2454d032706cc5b704 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96433 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6862
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6862
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be2dee69f57c6944df7e76b910a7d86b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66482d03fe4ff101b54019dc3bdccc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a556c6d80932400b5a4c96f0a7948ce2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3b3b7fd39b75cc7de9ef6a7e8b3574c |
| publicationDate |
2022-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-4003416-A1 |
| titleOfInvention |
C3/c5 convertase assays |
| abstract |
The present invention concerns a method for classifying a disorder associated with the complement system comprising the detection of the presence of C3/C5 convertase complexes as well as Ig/C1q and MBL/MASP complexes. Moreover the invention refers to a method for determining whether a patient will be responsive to a modulator of the complements system, a method for determining the disorder course of a patient with a disorder associated with the complement system and a method for determining whether a candidate compound is suitable for the treatment of a disorder if the complement system and the respective kits. |
| priorityDate |
2019-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |